Exclusive: ACR Convergence 2024 | Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Conditions
FocusRheum
Guidance
Drug Updates
- Analgesics
- Biologics/DMARDs
Practice Support
- Billing/Coding
- EMRs
- Facility
- Insurance
- QA/QI
- Technology
- Workforce
Opinion
Career
ACR
Search

Difficult-to-Treat Lupus: When & How to Use New Therapies

Samantha C. Shapiro, MD | Issue: September 2022 | July 21, 2022

Page: 1 2 3 4 | Single Page

Share:

Filed under:Conditions EULAR/Other Meeting Reports Systemic Lupus Erythematosus Tagged with:belimumab EULAR HCQ Hydroxychloroquine (HCQ)rituximab SLE systemic lupus erythematosus (SLE)

Related Articles

TNF Blockade for SLE

September 1, 2010

Reckless approach versus missed opportunity?

Top 12: Research in Systemic Lupus Erythematosus at a Glance

November 18, 2021

Dr. Pisetsky’s picks for the top research in lupus presented at ACR Convergence 2021.

T Cells in Systemic Lupus Erythematosus

August 1, 2011

Progress toward targeted therapy

Mitigate Risk and Increase Success of Lupus Clinical Trials

August 1, 2010

Design strategies from a Lupus Research Institute conference

About Us
Meet the Editors
Issue Archives
Contribute
Advertise
Contact Us

Copyright © 2000-2024 American College of Rheumatology. All rights reserved. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
DEI Statement
Privacy Policy
Terms of Use
Cookie Preferences